Treatment of Alcohol Withdrawal in Hospital Patients

Completed · Phase 4

Conditions studied: Alcohol Withdrawal Syndrome

In brief

The purpose of this study is to test how tolerable and effective lorazepam is when used to treat alcohol withdrawal in hospital patients at risk for alcohol withdrawal.

Key facts

Study ID

NCT00249366

Run by

Virginia Commonwealth University

People needed

183

Starts

2001-04-01

Expected to finish

2003-05-01

Last updated by the study team

2016-04-11

Who can join

Age: 21 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Alcohol dependence (based on criteria from the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition)
• Daily alcohol use for at least seven consecutive days with the last use no more than 72 hours prior to enrollment
• Patients on the General Internal Medicine service

You may not qualify if…

• Unable to give informed consent
• Chronically maintained on prescription sedative-hypnotics

Where it is running

• Virginia Commonwealth University Medical Center — Richmond, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.